BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10453465)

  • 21. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.
    Heinricher MM; McGaraughty S; Grandy DK
    J Neurophysiol; 1997 Dec; 78(6):3351-8. PubMed ID: 9405549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of NOC/oFQ in impaired opioid-induced pial artery dilation following brain injury.
    Armstead WM
    Brain Res; 2000 Jun; 869(1-2):231-5. PubMed ID: 10865080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship studies on the novel neuropeptide orphanin FQ.
    Reinscheid RK; Ardati A; Monsma FJ; Civelli O
    J Biol Chem; 1996 Jun; 271(24):14163-8. PubMed ID: 8662940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.
    Nakano H; Minami T; Abe K; Arai T; Tokumura M; Ibii N; Okuda-Ashitaka E; Mori H; Ito S
    J Pharmacol Exp Ther; 2000 Jan; 292(1):331-6. PubMed ID: 10604967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocistatin: milestone of one decade of research.
    Okuda-Ashitaka E; Ito S
    Curr Pharm Des; 2015; 21(7):868-84. PubMed ID: 25345611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cAMP and K(+) channel-dependent mechanisms in piglet hypoxic/ischemic impaired nociceptin/orphanin FQ-induced cerebrovasodilation.
    Ben-Haim G; Armstead WM
    Brain Res; 2000 Nov; 884(1--2):51-8. PubMed ID: 11082486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nociceptin/orphanin FQ-like opioid peptide in nervous periesophageal ganglia of land snail Helix aspersa.
    León-Olea M; Miller-Pérez C; Sánchez-Islas E; Mendoza-Sotelo J; Garduño-Gutiérrez R; de Gortari P; Amaya MI
    Brain Res; 2013 Apr; 1505():22-46. PubMed ID: 23419890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic localization of (125)I[Tyr(14)]orphanin FQ/nociceptin and (125)I[Tyr(10)]orphanin FQ/nociceptin(1-11) binding sites in rat brain.
    Letchworth SR; Mathis JP; Rossi GC; Bodnar RJ; Pasternak GW
    J Comp Neurol; 2000 Jul; 423(2):319-29. PubMed ID: 10867661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.
    Jenck F; Moreau JL; Martin JR; Kilpatrick GJ; Reinscheid RK; Monsma FJ; Nothacker HP; Civelli O
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14854-8. PubMed ID: 9405703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Nociceptin/Orphanin FQ System and the Regulation of Memory.
    Moulédous L
    Handb Exp Pharmacol; 2019; 254():259-278. PubMed ID: 30430261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
    Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
    Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-Dependent vasopressinergic modulation of Noc/oFQ-induced impairment of NMDA cerebrovasodilation after brain injury.
    Armstead WM
    J Neurotrauma; 2001 Jun; 18(6):615-23. PubMed ID: 11437084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOC/oFQ contributes to hypoxic-ischemic impairment of N-methyl-D-aspartate-induced cerebral vasodilation.
    Armstead WM
    Brain Res; 2000 Jun; 868(1):48-55. PubMed ID: 10841887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between nociceptin/orphanin FQ and cerebral hemodynamics after hypoxia-ischemia in piglets.
    Armstead WM
    Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H477-83. PubMed ID: 10666078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic AMP analogs induce synthesis, processing, and secretion of prepro nociceptin/orphanin FQ-derived peptides by NS20Y neuroblastoma cells.
    Sirianni MJ; Fujimoto KI; Nelson CS; Pellegrino MJ; Allen RG
    DNA Cell Biol; 1999 Jan; 18(1):51-8. PubMed ID: 10025508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nociceptin/orphanin FQ contributes to hypoxic/ischemic impairment of hypercapnic cerebrovasodilation.
    Jagolino A; Armstead WM
    Brain Res Bull; 2001 Jul; 55(4):465-8. PubMed ID: 11543945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological Actions of N/OFQ.
    Winters BL; Christie MJ; Vaughan CW
    Handb Exp Pharmacol; 2019; 254():91-130. PubMed ID: 30838458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury.
    Kulkarni M; Armstead WM
    J Neurotrauma; 2002 Aug; 19(8):965-73. PubMed ID: 12225656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.
    Mathis JP; Rossi GC; Pellegrino MJ; Jimenez C; Pasternak GW; Allen RG
    Brain Res; 2001 Mar; 895(1-2):89-94. PubMed ID: 11259764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
    Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.